The 3CTN EDI Framework and Toolkit is Launched
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical trial conduct! This comprehensive EDI Framework and Toolkit resource are the products of an expert working group comprised of 3CTN members, trial sponsors, and people with lived experience from underrepresented communities. The resulting materials are available and accessible on the 3CTN website for the benefit of all in the research community. To access, please go to https://3ctn.ca/equity-diversity-and-inclusion-in-clinical-trials/.

The Canadian Institutes of Health Research (CIHR) is recruiting members to join one of its 13 Institute Advisory Boards (IABs). New members will be invited to serve a first term of three years beginning on January 1, 2025. Members from all communities...
The Canadian Partnership Against Cancer is working with partners across Canada to accelerate and introduce programs that will restore and sustain cancer care.